Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NiproNPRRF 72 Market Cap is $1,647 Mil as of Aug. 05, 2026. GuruFocus rates NPRRF with a GF Score™ of 72/100 and a GF Value™ of $9.30. The stock has 6 warning signs investors should review. Among 863 Medical Devices & Instruments companies, Nipro ranks better than 85.05% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nipro's share price for the quarter that ended in Mar. 2026 was $9.96. Nipro's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 163 Mil. Therefore, Nipro's market cap for the quarter that ended in Mar. 2026 was $1,624 Mil.
Nipro's quarterly market cap
stayed the same
from Sep. 2025 ($1,342 Mil) to Dec. 2025 ($1,342 Mil) but then
increased
from Dec. 2025 ($1,342 Mil) to Mar. 2026 ($1,624 Mil).
Nipro's annual market cap
declined
from Mar. 2024 ($1,386 Mil) to Mar. 2025 ($1,342 Mil) but then
increased
from Mar. 2025 ($1,342 Mil) to Mar. 2026 ($1,624 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nipro's Enterprise Value for Today is $5,480 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nipro Market Cap Related Terms
Nipro Market Cap Historical Data
* Premium members only.
The historical data trend for Nipro's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Nipro's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nipro Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Market Cap distribution charts can be found below:
* The bar in red indicates where Nipro's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nipro's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nipro (NPRRF) has a Market Cap of $1,647 Mil as of Aug. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nipro and its competitors. According to the industry distribution chart, Nipro ranks #129 out of 863 companies in the Medical Devices & Instruments industry, placing it in the top 14.9%.
Is Nipro's Market Cap too high?
Nipro's current Market Cap is $1,647 Mil. The Medical Devices & Instruments industry median Market Cap is 116.79. Nipro's value of $1,647 Mil is 1310.2% above this industry median. Based on the distribution chart, Nipro ranks #129 out of 863 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nipro has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Nipro's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nipro ranks #129 out of 863 companies for Market Cap. This places Nipro in the top 15% of its industry — outperforming the majority of peers. The industry median Market Cap is 116.79. Nipro's value of $1,647 Mil is 1310.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.79, based on 863 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nipro's current Market Cap of $1,647 Mil is 1310.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nipro and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nipro's current Market Cap is $1,647 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Nipro (NPRRF) has a current Market Cap of $1,647 Mil. The stock's GF Value™ is $9.30, compared to a current price of $9.96 — trading 7.1% above its estimated fair value. The current Market Cap is $1,647 Mil and 1310.2% above the Medical Devices & Instruments industry median of 116.79. Nipro's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nipro (NPRRF), the current Market Cap is $1,647 Mil as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nipro (NPRRF) Overvalued in 2026?
Based on GuruFocus' analysis, Nipro stock appears to be overvalued.
The current stock price of $9.96 is trading 7.1% above its estimated GF Value™ of $9.30.
Key valuation signals for NPRRF:
Market Cap: $1,647 Mil
GF Value™: $9.30 vs. price of $9.96 (7.1% above fair value)
Industry Position: 1310.2% above the Medical Devices & Instruments median (#129 of 863)
No single metric tells the full story. See the NPRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
72GF Score
Get the complete analysis for NPRRF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NPRRF has been successfully added to your 
